Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cencora, Inc. (COR : NYSE)
 
 • Company Description   
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

Number of Employees: 51,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $331.00 Daily Weekly Monthly
20 Day Moving Average: 1,246,001 shares
Shares Outstanding: 190.83 (millions)
Market Capitalization: $63,163.73 (millions)
Beta: 0.58
52 Week High: $377.54
52 Week Low: $244.82
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 6.82% 7.95%
12 Week 6.01% 3.42%
Year To Date -2.00% -10.48%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1 West First Avenue
-
Conshohocken,PA 19428
USA
ph: 610-727-7000
fax: 800-640-5221
investorrelations@cencora.com http://www.cencora.com
 
 • General Corporate Information   
Officers
Robert P. Mauch - Chief Executive Officer;President and Director
D. Mark Durcan - Chairman and Director
James F. Cleary - Executive Vice President and Chief Financial Offic
Lazarus Krikorian - Senior Vice President and Chief Accounting Officer
Werner Baumann - Director

Peer Information
Cencora, Inc. (CHCR)
Cencora, Inc. (ESRX)
Cencora, Inc. (MYDP)
Cencora, Inc. (COR)
Cencora, Inc. (GBCS)
Cencora, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 03073E105
SIC: 5122
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/04/26
Share - Related Items
Shares Outstanding: 190.83
Most Recent Split Date: 6.00 (2.00:1)
Beta: 0.58
Market Capitalization: $63,163.73 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.73%
Current Fiscal Quarter EPS Consensus Estimate: $4.68 Indicated Annual Dividend: $2.40
Current Fiscal Year EPS Consensus Estimate: $19.77 Payout Ratio: 0.14
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: -0.02
Estmated Long-Term EPS Growth Rate: 9.88% Last Dividend Paid: 08/14/2026 - $0.60
Next EPS Report Date: 11/04/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 16.74
Trailing 12 Months: 19.30
PEG Ratio: 1.70
Price Ratios
Price/Book: 19.50
Price/Cash Flow: 15.32
Price / Sales: 0.19
EPS Growth
vs. Year Ago Period: 12.00%
vs. Previous Quarter: -5.68%
Sales Growth
vs. Year Ago Period: 5.07%
vs. Previous Quarter: 8.17%
ROE
09/30/26 - -
06/30/26 - 125.45
03/31/26 - 135.20
ROA
09/30/26 - -
06/30/26 - 4.18
03/31/26 - 4.20
Current Ratio
09/30/26 - -
06/30/26 - 0.93
03/31/26 - 0.95
Quick Ratio
09/30/26 - -
06/30/26 - 0.58
03/31/26 - 0.59
Operating Margin
09/30/26 - -
06/30/26 - 1.01
03/31/26 - 0.99
Net Margin
09/30/26 - -
06/30/26 - 0.79
03/31/26 - 0.78
Pre-Tax Margin
09/30/26 - -
06/30/26 - 1.08
03/31/26 - 1.07
Book Value
09/30/26 - -
06/30/26 - 16.97
03/31/26 - 18.43
Inventory Turnover
09/30/26 - -
06/30/26 - 14.93
03/31/26 - 14.93
Debt-to-Equity
09/30/26 - -
06/30/26 - 3.53
03/31/26 - 3.40
Debt-to-Capital
09/30/26 - -
06/30/26 - 77.94
03/31/26 - 77.26
 

Powered by Zacks Investment Research ©